COSIBELIMAB-IPDL | B761297 | CHECKPOINT THERAPEUTICS INC
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Dec. 13, 2036 | Active | Computed |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12403070(formulation) · relevance 50/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
8 AI-discovered patents, sorted by relevance.
No patent or exclusivity listings for this strength.